Mandeep Bajaj

Dr. Mandeep Bajaj and other experts talk about type 5 diabetes and the need for more research on it. bit.ly/46IY5YO #diabetes

New 2026 ADA Standards of Care include updated recommendations on diabetes technology, glucose-lowering therapies, and obesity treatment. Stay current with evidence-based practice: diabetes.org/newsroom/press… #DiabetesEducation #ADAStandards

Big congratulations to Drs. Fasiha Kanwal and Mandeep Bajaj for helping shape national guidance on liver disease in diabetes as contributors to the ADA’s newly published consensus statement. A major honor and impactful achievement! Read more: diabetesjournals.org/care/article/d…

This holiday season, Dr. Mandeep Bajaj shares tips for those on GLP-1 medications: enjoy smaller portions, choose whole foods, stay hydrated, and avoid excess sugar. Keep your health goals on track while celebrating! 🥐🥧🍗 #HealthyHolidays Read more: bcm.edu/news/holiday-e…

Congratulations to Dr. Mandeep Bajaj on being named Co-Chair of the American Diabetes Association’s Professional Practice Committee for the 2026 Standards of Care in Diabetes! His leadership will help shape the future of diabetes care worldwide. 👏

Dr. Mandeep Bajaj takes the stage at the Nancy Chang, Ph.D. Research Symposium! His talk, ‘Metabolic Effects of GLP-1 Receptor Agonists: Looking Beyond Weight Loss,’ explores benefits for MASH and cardiovascular disease, highlighting exciting new clinical insights.

Dr. Mandeep Bajaj has been named President-elect of the American Diabetes Association (@AmDiabetesAssn). He will be the first BCM physician to serve as President of the ADA, & his term will start in January 2024. Congratulations, Dr. Bajaj! #BCMDoM

@mandeepbajaj65 and other experts explore the first-ever ADA guidelines on liver disease in diabetes. 🔗 Read more: bit.ly/3GeAPrw #ADASciSessions

🚨 New ADA Consensus Report: A multidisciplinary call to action on NAFLD and MAFLD in people with diabetes. Learn how early detection, screening, and team-based care can change outcomes. 📰 Read now: diabetesjournals.org/care/lookup/do… #Diabetes #NAFLD #MAFLD @AmDiabetesAssn @ADA_DiabetesPro @DiabetesCareADA

It was an honor to represent @TheAACE to discuss the management of #MASLD with this esteemed panel of experts @mandeepbajaj65, president of @AmDiabetesAssn, @CSMantzoros, @Mayo_liverdoc and @ZobairYounossi at the Liver Connect meeting for @CLDFoundation.

🚨Exciting new statement from ADA on compounded GLP-1 RA and dual GIP and GLP-1 RA products🚨 @JoshuaNeumiller @mandeepbajaj65 @RozalinaMD @nuhaaelsayed diabetesjournals.org/care/article/d…

When initiated earlier in the disease course, GLP-1 receptor agonists are associated with a reduced risk of progression to cirrhosis in patients with metabolic dysfunction-associated steatotic liver disease. ja.ma/3XHgcdw

Presidential address - The new ADA President - Indian origin Dr Mandeep Bajaj. Proud day for Indian Diabetologists!

Presidential oration @ADA_DiabetesPro @AmDiabetesAssn ..Prof Mandeep Bajaj of Indian Origin...Texas now @Baylor #ADA2024..

Indian Origin Prof Mandeep Bajaj President ADA ...Medicine and Science ..#ADA2024..@ADA_DiabetesPro @AmDiabetesAssn @ChuckatADA @DrBobGabbay ...

Congratulations Mandeep Bajaj, MBBS, FRCP on receiving the 2023 National Scientific & Health Care Achievement Award, Outstanding Physician-Clinician in Diabetes Award! #ADA2023 bit.ly/43T7Q38

ADA TV's next guest in the studio at the #ADASciSessions serves as ADA President of Medicine and Science and for Dr. Mandeep Bajaj, fighting Diabetes is a journey that began in childhood. youtu.be/_WPE_IRKWR0 @ADA_DiabetesPro

The dedication and persistence of the #Diabetes & #Endocrinology team at @bcmhouston paid off! We were ranked nationally by @usnews and received a high performing award; a well-earned recognition for this hard-working group @bcmhouston. #DiabetesCare

Had a wonderful few days at #ADASciSessions getting to meet many wonderful minds (shoutout to our awesome PPC members and consensus report panels) and partaking in a symposium about liver health in diabetes #diabetes #MASLD #MASH